Gold Royalty (AMEX:GROY) reported $1.90 million in sales this quarter.
Looking Into DarioHealth’s Return On Capital Employed
Benzinga Pro data, DarioHealth (NASDAQ:DRIO) reported Q2 sales of $6.18 million. Earnings fell to a loss of $18.03 million, resulting in a 13.27% decrease from last quarter.